{
    "Trade/Device Name(s)": [
        "ADVIA Centaur IgE Master Curve Material"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K143680",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133122"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "December 19, 2014",
    "Summary Letter Received Date": "January 5, 2015",
    "Submission Date": "January 26, 2015",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgE"
    ],
    "Specimen Type(s)": [
        "Human plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur Systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur IgE Master Curve Material, a quality control material for calibration verification in IgE assays on ADVIA Centaur Systems",
    "Indications for Use Summary": "For in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur Total IgE assay",
    "fda_folder": "Clinical Chemistry"
}